Health
World News | Longer Gap in Pfizer-BioNTech COVID Vaccines Boosts Antibody Levels: Study – LatestLY
Get latest articles and stories on World at LatestLY. A longer gap between first and second doses of the Pfizer-BioNTech COVID-19…
London, Jul 24 (PTI) A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with…
Continue Reading
-
Business22 hours agoHeres a 5-stock portfolio to consider to aim for $1k a month in passive income
-
Noosa News21 hours agoQueensland passes laws restricting use of good character references in sentencing convicted sex offenders
-
Noosa News22 hours agoImmigration needs to be managed, says MP Llew O’Brien
-
General23 hours agoAustralia set to unveil contested 2035 climate target